The progressive neurological abnormalities are seen primarily in XP patients belonging to the CGs in which both NER subpathways are compromised (Table 1): XP-D and XP-A (followed by XP-B, XP-G, and XP-F) [13,14,64,65]. The gene discussed is ERCC3; the disease is xeroderma pigmentosum.